Spectrum Pharmaceuticals Shares Outstanding 2006-2019 | SPPI

Spectrum Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Spectrum Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 111
2018 103
2017 85
2016 73
2015 65
2014 65
2013 61
2012 65
2011 58
2010 50
2009 39
2008 32
2007 29
2006 24
2005 18
Spectrum Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2019-12-31 111
2019-09-30 111
2019-06-30 110
2019-03-31 110
2018-12-31 103
2018-09-30 104
2018-06-30 113
2018-03-31 101
2017-12-31 85
2017-09-30 83
2017-06-30 79
2017-03-31 79
2016-12-31 73
2016-09-30 79
2016-06-30 69
2016-03-31 66
2015-12-31 65
2015-09-30 66
2015-06-30 65
2015-03-31 65
2014-12-31 65
2014-09-30 65
2014-06-30 65
2014-03-31 63
2013-12-31 61
2013-09-30 62
2013-06-30 59
2013-03-31 59
2012-12-31 65
2012-09-30 65
2012-06-30 63
2012-03-31 65
2011-12-31 58
2011-09-30 59
2011-06-30 58
2011-03-31 56
2010-12-31 50
2010-09-30 50
2010-06-30 49
2010-03-31 49
2009-12-31 39
2009-09-30 44
2009-06-30 34
2009-03-31 32
2008-12-31 32
2008-09-30 32
2008-06-30 32
2008-03-31 31
2007-12-31 29
2007-09-30 31
2007-06-30 28
2007-03-31 25
2006-12-31 24
2006-09-30 24
2006-06-30 24
2006-03-31 24
2005-12-31 18
2005-09-30 17
2005-06-30 15
2005-03-31 15
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.284B $0.109B
Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.999B 32.39
Takeda Pharmaceutical (TAK) Japan $47.260B 8.28
Astellas Pharma (ALPMY) Japan $27.822B 13.90
Eisai (ESALY) Japan $20.849B 38.84
Grifols, S.A (GRFS) Spain $13.421B 16.68
Merck (MKGAF) Germany $12.451B 16.33
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.539B 237.23
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.384B 30.38
Ionis Pharmaceuticals (IONS) United States $6.926B 20.99
Jazz Pharmaceuticals (JAZZ) Ireland $5.655B 6.90
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.299B 0.00
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.549B 0.00
IPSEN SA ADR (IPSEY) France $4.173B 0.00
United Therapeutics (UTHR) United States $4.038B 0.00
Hypermarcas (HYPMY) Brazil $3.970B 12.08
Evotec AG (EVTCY) Germany $3.485B 56.21
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 57.72
Nektar Therapeutics (NKTR) United States $3.109B 0.00
FibroGen (FGEN) United States $2.976B 0.00
PTC Therapeutics (PTCT) United States $2.720B 0.00
ChemoCentryx (CCXI) United States $2.460B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.375B 9.61
Xencor (XNCR) United States $1.725B 70.44
Sage Therapeutics (SAGE) United States $1.607B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.595B 19.39
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.578B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.467B 0.00
Karyopharm Therapeutics (KPTI) United States $1.392B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.364B 37.29
USANA Health Sciences (USNA) United States $1.344B 14.11
Corcept Therapeutics (CORT) United States $1.261B 14.10
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Heron Therapeutics (HRTX) United States $1.084B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.032B 14.38
Esperion Therapeutics (ESPR) United States $1.029B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.991B 30.69
Akebia Therapeutics (AKBA) United States $0.977B 0.00
Endo (ENDP) Ireland $0.855B 1.58
Tilray (TLRY) Canada $0.822B 0.00
Radius Health (RDUS) United States $0.666B 0.00
Molecular Templates (MTEM) United States $0.658B 0.00
Aerie Pharmaceuticals (AERI) United States $0.627B 0.00
ImmunoGen (IMGN) United States $0.617B 0.00
Translate Bio (TBIO) United States $0.615B 0.00
Collegium Pharmaceutical (COLL) United States $0.583B 0.00
Portola Pharmaceuticals (PTLA) United States $0.551B 0.00
Indivior (INVVY) United States $0.509B 3.03
Corbus Pharmaceuticals Holdings (CRBP) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.402B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.402B 13.41
Ardelyx (ARDX) United States $0.395B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.390B 15.99
Innate Pharma SA (IPHYF) France $0.385B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.385B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.374B 0.00
Organogenesis Holdings (ORGO) United States $0.373B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.352B 0.00
TherapeuticsMD (TXMD) United States $0.350B 0.00
Flexion Therapeutics (FLXN) United States $0.337B 0.00
Trillium Therapeutics (TRIL) Canada $0.325B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Harpoon Therapeutics (HARP) United States $0.301B 0.00
DURECT (DRRX) United States $0.294B 0.00
Lannett Co Inc (LCI) United States $0.291B 4.69
Calithera Biosciences (CALA) United States $0.289B 0.00
Concert Pharmaceuticals (CNCE) United States $0.273B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.270B 0.00
Ocular Therapeutix (OCUL) United States $0.257B 0.00
CASI Pharmaceuticals (CASI) United States $0.222B 0.00
OptiNose (OPTN) United States $0.191B 0.00
Rafael Holdings (RFL) United States $0.189B 0.00
Recro Pharma (REPH) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 22.15
MEI Pharma (MEIP) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 3.07
PROFOUND MEDICL (PROF) Canada $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.154B 0.00
KalVista Pharmaceuticals (KALV) United States $0.137B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Taiwan Liposome (TLC) Taiwan $0.128B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.106B 0.00
CannTrust Holdings (CTST) Canada $0.105B 0.00
Redhill Biopharma (RDHL) Israel $0.097B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
IMV INC (IMV) Canada $0.087B 0.00
Xeris Pharmaceuticals (XERS) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.078B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.073B 0.00
CV Sciences (CVSI) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.068B 0.00
Aquestive Therapeutics (AQST) United States $0.068B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Otonomy (OTIC) United States $0.063B 0.00
Hemispherx BioPharma (AIM) United States $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 17.62
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
PharmAthene (ALT) United States $0.050B 0.00
Aclaris Therapeutics (ACRS) United States $0.049B 0.00
PolarityTE (PTE) United States $0.048B 0.00
MediWound (MDWD) Israel $0.046B 0.00
Onconova Therapeutics (ONTX) United States $0.045B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
GTx (ONCT) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 19.19
AgeX Therapeutics (AGE) United States $0.042B 0.00
Neos Therapeutics (NEOS) United States $0.041B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.29
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
IsoRay (ISR) United States $0.039B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.026B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
India Globalization Capital (IGC) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.024B 7.55
Bellicum Pharmaceuticals (BLCM) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Novan (NOVN) United States $0.020B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.014B 0.00
ElectroCore (ECOR) United States $0.014B 0.00
Vical (BBI) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.005B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00